Dysregulation of IFN system can lead to poor response to pegylated interferon and ribavirin therapy in chronic hepatitis C
about
A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virusGenetic variants at the IFNL3 locus and their association with hepatitis C virus infections reveal novel insights into host-virus interactionsEvaluation of database-derived pathway development for enabling biomarker discovery for hepatotoxicityMeta-analysis: implications of interleukin-28B polymorphisms in spontaneous and treatment-related clearance for patients with hepatitis C.Gene expression profiling to predict and assess the consequences of therapy-induced virus eradication in chronic hepatitis C virus infection.Baseline gene expression signatures in monocytes from multiple sclerosis patients treated with interferon-betaThe Impact of IL28B Genotype and Liver Fibrosis on the Hepatic Expression of IP10, IFI27, ISG15, and MX1 and Their Association with Treatment Outcomes in Patients with Chronic Hepatitis C.Newcastle Disease Virus V Protein Targets Phosphorylated STAT1 to Block IFN-I Signaling.Genetics of IL28B and HCV--response to infection and treatment.Elevated hepatic lipid and interferon stimulated gene expression in HCV GT3 patients relative to non-alcoholic steatohepatitis.Increased expression and dysregulated association of restriction factors and type I interferon in HIV, HCV mono- and co-infected patients.
P2860
Q24307721-D92AEF3C-8A05-480B-9590-390DFCBBD021Q27014831-D674B8A4-F3D9-41E5-B6CC-CCA6ECB11E65Q27027301-4078E45D-BBB2-4C36-84E5-5AF1873923BCQ34539324-E2020453-0B43-41B5-B392-92BB28964E06Q34593704-4F604561-76FD-4A65-8301-82B8542FC761Q34700070-C56989B5-CCDE-41A3-9FE6-F227A331AC7CQ35675852-977138EC-785A-4A6A-8DBD-043F17161D39Q35918371-C3147219-9454-4A8A-B4AF-DC1C51553117Q38013941-7E25455B-07BD-4F6F-B128-58477FA9619CQ40484068-D2D25E0B-E020-45B7-83C9-ACD3C99A5363Q40929061-29DDA5D6-E53E-463B-8B3D-98D41CE87C1B
P2860
Dysregulation of IFN system can lead to poor response to pegylated interferon and ribavirin therapy in chronic hepatitis C
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Dysregulation of IFN system ca ...... therapy in chronic hepatitis C
@ast
Dysregulation of IFN system ca ...... therapy in chronic hepatitis C
@en
Dysregulation of IFN system ca ...... therapy in chronic hepatitis C
@nl
type
label
Dysregulation of IFN system ca ...... therapy in chronic hepatitis C
@ast
Dysregulation of IFN system ca ...... therapy in chronic hepatitis C
@en
Dysregulation of IFN system ca ...... therapy in chronic hepatitis C
@nl
prefLabel
Dysregulation of IFN system ca ...... therapy in chronic hepatitis C
@ast
Dysregulation of IFN system ca ...... therapy in chronic hepatitis C
@en
Dysregulation of IFN system ca ...... therapy in chronic hepatitis C
@nl
P2093
P2860
P1433
P1476
Dysregulation of IFN system ca ...... therapy in chronic hepatitis C
@en
P2093
Fumihiko Matsuda
Hidenori Toyoda
Kazuko Uno
Koji Onomoto
Kunitada Shimotohno
Masahiko Kuroda
Masami Tanaka
Shiho Morimoto
Takahisa Kawaguchi
Takashi Fujita
P2860
P304
P356
10.1371/JOURNAL.PONE.0019799
P407
P577
2011-01-01T00:00:00Z